Jw Pharmac (001060) — Capital Reinvestment Ratio

Latest as of December 2025: 0.49x

Jw Pharmac (001060) has a Capital Reinvestment Ratio of 0.49x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩27.55 Billion) in capital expenditures (₩13.49 Billion). See 001060 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.49x
Capex / Operating Cash Flow

Operating Cash Flow

₩27.55 Billion
KRW

Capital Expenditures

₩13.49 Billion
KRW

Data as of

Dec 2025
Most recent filing

Jw Pharmac Capital Reinvestment Ratio (2001–2025)

This chart tracks Jw Pharmac's Capital Reinvestment Ratio across 19 annual periods.

Annual Capital Reinvestment Ratio for Jw Pharmac (2001–2025)

Year-by-year Capital Reinvestment Ratio for Jw Pharmac from 2001 to 2025. For live market cap and broader valuation context, see market cap of Jw Pharmac.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.37x ₩96.40 Billion ₩36.12 Billion ▲ +5.7%
2024 0.35x ₩79.39 Billion ₩28.14 Billion ▼ -24.1%
2023 0.47x ₩87.16 Billion ₩40.71 Billion ▲ +167.3%
2022 0.17x ₩56.76 Billion ₩9.92 Billion ▼ -57.6%
2021 0.41x ₩18.12 Billion ₩7.47 Billion ▲ +109.7%
2020 0.20x ₩63.05 Billion ₩12.39 Billion ▲ +17.5%
2019 0.17x ₩55.53 Billion ₩9.28 Billion ▲ +0.9%
2018 0.17x ₩52.11 Billion ₩8.64 Billion ▼ -26.1%
2017 0.22x ₩33.45 Billion ₩7.50 Billion ▼ -84.9%
2016 1.49x ₩6.74 Billion ₩10.02 Billion ▲ +56.2%
2014 0.95x ₩7.28 Billion ₩6.93 Billion ▲ +316.2%
2013 0.23x ₩18.72 Billion ₩4.28 Billion ▼ -4.3%
2012 0.24x ₩64.21 Billion ₩15.35 Billion ▼ -97.3%
2006 8.93x ₩5.07 Billion ₩45.32 Billion ▲ +541.9%
2005 1.39x ₩70.25 Billion ₩97.76 Billion ▼ -24.0%
2004 1.83x ₩15.02 Billion ₩27.50 Billion ▲ +170.5%
2003 0.68x ₩17.05 Billion ₩11.54 Billion ▲ +54.3%
2002 0.44x ₩28.74 Billion ₩12.61 Billion ▲ +18.8%
2001 0.37x ₩45.04 Billion ₩16.63 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow